Autopsy report · NCT00306267
A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy
Cause of deathOther
“Study stopped as it would not address important survival concerns raised in other recently conducted clinical studies.”
Life of this trial
- Ran for about 1 year 2 months before it stopped.
- 61 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Sponsor type
- Industry
- Conditions
- Anemia; Cancer; Epoetin Alfa
- Interventions
- epoetin alfa
- Participants
- 61
Trials that died the same way
- An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis
“The study was stopped due to a non-clinical safety finding.” - Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
“Study stopped due to lack of efficacy.” - Assessment of Artificial Intelligence Algorithms for ROTEM
“The study was stopped because it was considered unlikely that the required number of patients could be prospectively recruited across the participating study centers.” - Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke
“study was stopped for business/administrative reasons and not for patient safety concerns” - Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta
“Sponsor decision to prematurely stop the study, not linked to any safety concern.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.